NCT01339832View on ClinicalTrials.gov

An Observational Study of Xeloda (Capecitabine) and Oxaliplatin Prior and Concurrent To Preoperative Pelvic Radiotherapy in Patients With Locally Advanced Rectal Cancer

CompletedOBSERVATIONAL
Enrollment

51

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Colorectal Cancer
Trial Locations (5)

4031

Basel

6004

Lucerne

7000

Chur

8063

Zurich

9007

Sankt Gallen

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Hoffmann-La Roche

INDUSTRY

NCT01339832 - An Observational Study of Xeloda (Capecitabine) and Oxaliplatin Prior and Concurrent To Preoperative Pelvic Radiotherapy in Patients With Locally Advanced Rectal Cancer | Biotech Hunter | Biotech Hunter